Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

BK7508 Pharmaceutical Companies

Market Closed 07-17 16:00:00 AEST

495.85

+0.21

+0.04%

High504.88	Low489.91	Vol67.16M
Open498.51	D1 Closing495.65	Amplitude3.02%
Mkt Cap0.00	Tradable Cap0.00	Total Shares0.00
T/O205.28M	T/O Rate--	Tradable Shares0.00
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BK7508","market":"AU","secType":"PLATE","nameCN":"Pharmaceutical Companies","latestPrice":495.85464,"timestamp":1784267999851,"preClose":495.64648,"halted":0,"volume":67161058,"delay":0,"changeRate":0.00042,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Market Closed","change":0.20816,"latestTime":"07-17 16:00:00 AEST","open":498.50763,"high":504.87704,"low":489.90817,"amount":205281752,"amplitude":0.030201,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1784505600000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1784246400000,1784268000000]],"turnoverRate":0.002634,"increases":5,"decrements":20,"flats":18,"marketCap":69156351475.25,"floatMarketCap":66134626035.375},"requestUrl":"/m/hq/s/BK7508/tweets","defaultTab":"tweets","newsList":[{"id":"2652407438","title":"Dimerix Acquires Phase 2-ready Acute Kidney Injury Drug Candidate Dmx-652 from Mission Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2652407438","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652407438?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:02","pubTimestamp":1784286128,"startTime":"0","endTime":"0","summary":"Dimerix acquires Phase 2-ready acute kidney injury drug candidate DMX-652 from Mission TherapeuticsDimerix acquired DMX-652 from Mission Therapeutics for all indications, adding a Phase 2-ready acute ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nNDLbGlB3s:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Dimerix Acquires Phase 2-ready Acute Kidney Injury Drug Candidate Dmx-652 from Mission Therapeutics","news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DXB.AU","BK7067","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652740715","title":"Dimerix - Buys Dmx-652 for All Indications from Mission Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2652740715","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652740715?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","DXB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652152407","title":"Dimerix - to Pay $5 Mln Upfront, up to $287 Mln in Milestones for Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2652152407","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652152407?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","BK7508","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652074884","title":"Dimerix - to Pay 8-10% Royalty on Global Net Sales of Dmx-652","url":"https://stock-news.laohu8.com/highlight/detail?id=2652074884","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652074884?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DXB.AU","BK7067","BK7501","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652040713","title":"Dimerix - Phase 2 Trial Ethics Approval Expected H2 2026, First Patient Dosing H1 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2652040713","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652040713?lang=en_us&edition=fundamental","pubTime":"2026-07-17 19:00","pubTimestamp":1784286002,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nTUA58K1YY:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","BK7508","DXB.AU","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652401885","title":"Founder Led Australian Stocks With The Clearest Growth Story Right Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2652401885","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652401885?lang=en_us&edition=fundamental","pubTime":"2026-07-17 16:32","pubTimestamp":1784277172,"startTime":"0","endTime":"0","summary":"With inflation readings, bond yields and energy headlines pulling markets in different directions, many investors are looking for leaders whose interests are tightly aligned with shareholders. Founder-led companies often fit that brief, with executives who have personal capital, reputation and legacy on the line. The Founder-Led Companies screener is built to surface these stocks so you can focus on businesses where leadership tends to think in years, not quarters. In this article, you will...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/4484222-main-header/1585186590706"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-australian-stocks-with-the-clearest-growth-story","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/consumer-services/asx-flt/flight-centre-travel-group-shares/news/founder-led-australian-stocks-with-the-clearest-growth-story","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MAQ.AU","BK7511","BK7046","IMLC.AU","OZF.AU","XKO.AU","BK7070","IIGF.AU","QFN.AU","ZYAU.AU","SLF.AU","XAO.AU","VAP.AU","E200.AU","VAS.AU","BK7067","BK7501","STW.AU","OZR.AU","XJO.AU","IOZ.AU","BK7508","DACE.AU","IISV.AU","MQG.AU","QRE.AU","GIVE.AU","MSB.AU","GEAR.AU","BK7043","BBOZ.AU","BEAR.AU","FLT.AU","BK7042","EIGA.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652940871","title":"Mission Therapeutics Divests Mtx652 for Acute Kidney Injury to Dimerix","url":"https://stock-news.laohu8.com/highlight/detail?id=2652940871","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652940871?lang=en_us&edition=fundamental","pubTime":"2026-07-17 15:32","pubTimestamp":1784273522,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43I1WH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7501","DXB.AU","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652716408","title":"Mission Therapeutics: to Receive up to $292 Mln Plus Double-digit Tiered Royalties from Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2652716408","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652716408?lang=en_us&edition=fundamental","pubTime":"2026-07-17 15:32","pubTimestamp":1784273522,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nFWN43I1WH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","DXB.AU","BK7067","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652064471","title":"Dimerix Hits 'Major Milestone' With AU$10 Million Financing Package, Euroz Hartleys Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2652064471","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652064471?lang=en_us&edition=fundamental","pubTime":"2026-07-17 12:24","pubTimestamp":1784262255,"startTime":"0","endTime":"0","summary":"Dimerix's (ASX:DXB) AU$10 million financing package represents a \"major milestone\" as the company is now fully funded through the completion of its phase 3 focal segmental glomerulosclerosis study for","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7501","DXB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652476049","title":"Australia's Dimerix Rises on Funding Boost and Pipeline Acquisition","url":"https://stock-news.laohu8.com/highlight/detail?id=2652476049","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652476049?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:38","pubTimestamp":1784255930,"startTime":"0","endTime":"0","summary":"BUZZ-Australia's Dimerix rises on funding boost and pipeline acquisition** Shares of Australia's DimerixDXB.AXrise as much as 10.4% to A$0.265, their biggest intraday pct gain since July 6** Stock at its highest level since July 7** DXB stock set to mark its second consecutive session of gains, if trend holds** Stock up 2.1% in the week so far** The clinical stage biopharmaceutical firmsecuresa A$10 million  loan facility** Loan facility to support commercial manufacturing of DMX-200, a pill for kidney diseases, ahead of potential marketing approval submission and preparation for commercial launch, among others** Company separately says it expands pipeline with acquisition of DMX-652 for acute kidney injury** Near 4.7 million shares change hands, 1.5x the 30-day average** Stock has fallen 55.5% this year, including session moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260717:nL4N43J07T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","BK7501","DXB.AU","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652476089","title":"ASX Biggest Losers","url":"https://stock-news.laohu8.com/highlight/detail?id=2652476089","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652476089?lang=en_us&edition=fundamental","pubTime":"2026-07-17 10:31","pubTimestamp":1784255502,"startTime":"0","endTime":"0","summary":"Here are the ASX-listed companies with the biggest losses on Friday.EQ Resources : -10%, AU$0.22Mesoblast : -10%, AU$2.50Orezone Gold : -8%, AU$2.07Ora Banda Mining : -8%, AU$0.99Regis Resources : -8%, AU$5.69Sunrise Energy Metals : -7%, AU$15.744DMedical : -7%, AU$3.49Weebit Nano : -7%, AU$6.04Elsight : -7%, AU$6.74Metals X : -7%, AU$1.35","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["RRL.AU","ORE.AU","WBT.AU","BK7094","MSB.AU","ELS.AU","4DX.AU","BK7095","BK7501","BK7098","BK7069","EQR.AU","SRL.AU","BK7508","MLX.AU","BK7067","BK7084","OBM.AU","BK7507","BK7104"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652047509","title":"Dimerix Acquires Therapeutic Asset from UK-Based Firm; Shares Up 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652047509","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652047509?lang=en_us&edition=fundamental","pubTime":"2026-07-17 09:45","pubTimestamp":1784252758,"startTime":"0","endTime":"0","summary":"Dimerix  acquired therapeutic asset DMX-652 for all indications from UK-based Mission Therapeutics for an upfront payment of $5 million, expanding the company's pipeline in rare kidney disease, according to a Friday filing with the Australian bourse.The company will also pay up to $47 million in deferred acquisition fee payable upon success of pre-defined clinical development milestones, $40 million on product marketing approval, $25 million on approval in a second indication, and up to $175 million on specific sales milestones, the filing said.The acquisition includes assignment of the composition-of-matter patent, an open Investigational New Drug application in the US with a phase two clinical trial protocol, a pharmaceutical-grade drug product for the trial, and all manufacturing methodology, per the filing.Dimerix shares rose 8% in morning trade on Friday.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["DXB.AU","BK7501","BK7508","BK7067"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652175475","title":"AnteoTech Appoints Chief Financial Officer; Shares Down 8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652175475","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652175475?lang=en_us&edition=fundamental","pubTime":"2026-07-17 09:27","pubTimestamp":1784251668,"startTime":"0","endTime":"0","summary":"AnteoTech  appointed Scott Waddell as chief financial officer on a fixed-term contract until Dec. 16, 2028, according to a Friday filing with the Australian bourse.Waddell has been serving as the company's interim CFO since Feb. 2, and previously held the CFO role at other listed Australian mining firms, per the filing.AnteoTech shares fell 8% in recent Friday trade.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7036","ADO.AU","BK7508","BK7048","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652739754","title":"Dimerix Secures AU$10 Million Loan Facility From Substantial Shareholder Associate; Shares Up 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652739754","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652739754?lang=en_us&edition=fundamental","pubTime":"2026-07-17 08:39","pubTimestamp":1784248777,"startTime":"0","endTime":"0","summary":"Dimerix (ASX:DXB) entered into a loan facility agreement with Skiptan, an associate of substantial shareholder Peter Meurs, under which the lender has agreed to advance AU$10 million to the company at","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7067","BK7508","BK7501","DXB.AU","DMX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652478386","title":"Anteotech - Appoints Scott Waddell as CFO and Company Secretary Until 16 December 2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2652478386","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652478386?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:28","pubTimestamp":1784244490,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUE4SJCPK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7048","BK7501","ADO.AU","BK7036"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652389478","title":"Anteotech Ltd-appointment of CFO and Company Secretary","url":"https://stock-news.laohu8.com/highlight/detail?id=2652389478","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652389478?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:28","pubTimestamp":1784244490,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUE4SJCPK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7048","BK7508","ADO.AU","BK7501","BK7036"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652478801","title":"Mayne Pharma Group Names CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2652478801","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652478801?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:25","pubTimestamp":1784244353,"startTime":"0","endTime":"0","summary":"Mayne Pharma Group (ASX:MYX) appointed Griffin Buchanan as its Chief Financial Officer, effective Aug. 1, according to a Friday Australian bourse filing.He was most recently Vice President, Operational Finance at Establishment Labs.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652420035","title":"Dimerix Ltd-dimerix Expands Pipeline with Acquisition of Phase 2 Asset","url":"https://stock-news.laohu8.com/highlight/detail?id=2652420035","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652420035?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:03","pubTimestamp":1784242987,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUEWCH2R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7501","BK7067","BK7508","DXB.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652242008","title":"Dimerix Ltd - Initial A$10 Mln Loan Facility Secured","url":"https://stock-news.laohu8.com/highlight/detail?id=2652242008","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652242008?lang=en_us&edition=fundamental","pubTime":"2026-07-17 07:02","pubTimestamp":1784242924,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nFWN43I20B:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","DXB.AU","BK7508","BK7501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652442026","title":"Mayne Pharma Group - Appoints Griffin D. Buchanan as CFO Effective 1 August 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2652442026","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652442026?lang=en_us&edition=fundamental","pubTime":"2026-07-17 06:53","pubTimestamp":1784242389,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260716:nTUE5JM4ZK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["MYX.AU","BK7096","BK7508"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"compareEarnings":[{"period":"1week","weight":0.002},{"period":"1month","weight":0.0219},{"period":"3month","weight":0.0246},{"period":"6month","weight":0.0099},{"period":"1year","weight":0.1258},{"period":"ytd","weight":0.0343}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"name":"BK7508","nameEN":"BK7508"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Pharmaceutical Companies,BK7508,Pharmaceutical Companies股票,Pharmaceutical Companies股票老虎,Pharmaceutical Companies股票老虎国际,Pharmaceutical Companies行情,Pharmaceutical Companies股票行情,Pharmaceutical Companies股价,Pharmaceutical Companies股市,Pharmaceutical Companies股票价格,Pharmaceutical Companies股票交易,Pharmaceutical Companies股票购买,Pharmaceutical Companies股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Pharmaceutical Companies(BK7508),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Pharmaceutical Companies(BK7508) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction